(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
This volume forms part of a prestigious series and covers the latest advances in our understanding of the pathophysiology and treatment of asthma. Our understanding of asthma has changed dramatically in recent years, and much of this new information is brought together in this volume written by inter nationally recognised authorities. The aim of the book is to review in depth the changing concepts of inflammatory processes in asthma and to discuss the implications for research of this common chronic disease. Many of the advances in and future therapy our understanding of asthma have originated from a pharmacological approach, and this volume highlights the promising new options for pharma cological intervention. It is hoped this book will be invaluable for research scientists and clinic ians involved in asthma research and will be a major reference resource for chest physicians and those involved in the development of novel pharmaceu tical entities. Each chapter is extensively referenced, generously illustrated with clear diagrams and photographs, and represents a state-of-the-art review of this growing area. c.P. PAGE P.l. BARNES Contents CHAPTER 1 The Pathology of Asthma: An Overview L.A. LAmNEN and A. LAmNEN. With 10 Figures ...................... 1 A. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . 1 . . . . . . . . . . . . . . . B. Methods to Investigate the Pathology of Human Asthma ............ 1 C. Bronchial Epithelium and Inflammatory Cells in Asthmatic Patients Between Attacks ........................... 2 I. Mast Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . 4 . . . . . . . . . . . . . . II. Eosinophils ............................................... 7 III. Neutrophils.............................................. 10 D. Bronchial Epithelial Inflammation During an Asthma Attack. . . . . .. . 10 E. Epithelial Regeneration .... . . . . . . . . . . . . . . . . . . . . . . .. . . 12 . . . . . . . . .
Contents:
1 The Pathology of Asthma: An Overview.- A. Introduction.- B. Methods to Investigate the Pathology of Human Asthma.- C. Bronchial Epithelium and Inflammatory Cells in Asthmatic Patients Between Attacks.- I. Mast Cells.- II. Eosinophils.- III. Neutrophils.- D. Bronchial Epithelial Inflammation During an Asthma Attack.- E. Epithelial Regeneration.- F. Airway Smooth Muscle.- G. Bronchial Glands.- H. Neural Pathways.- I. Epithelium.- II. Neuroepithelial Bodies and Neuroendocrine-Like (Granule-Containing) Cells.- I. Nerves and Other Airway Structures.- J. Bronchial Circulation.- K. Leakage of the Bronchial Vascular Bed in Patients with Asthma.- L. Conclusion.- References.- 2 The Contribution of Inflammatory Cells to the Pathogenesis of Asthma.- A. Inflammation and Inflammatory Cells.- B. Pathological Evidence for Inflammation in Asthma.- C. Microvascular Leakage.- D. Neutrophils.- E. Eosinophils.- F. Mast Cells and Basophils.- G. Monocytes and Macrophages (Mononuclear Phagocytes).- H. Platelets.- I. Lymphocytes.- J. Concluding Comments.- References.- 3 Inflammatory Mediators.- A. Introduction.- I. Cellular Origin of Mediators.- II. Mediator Effects.- III. Mediator Receptors.- IV. Mediator Interactions.- V. Mediator Antagonists.- B. Histamine.- I. Synthesis and Metabolism.- II. Histamine Receptors.- III. Airway Effects.- IV. Role in Asthma.- C. Cyclooxygenase Products.- I. Synthesis and Metabolism.- II. Receptors.- III. Airway Effects.- 1. Airway Smooth Muscle.- 2. Secretion.- 3. Inflammatory Effects.- IV. Role in Asthma.- D. Lipoxygenase Products.- I. Synthesis and Metabolism.- II. Receptors.- III. Airway Effects.- 1. Airway Smooth Muscle.- 2. Secretion.- 3. Vascular Effects.- 4. Cellular Activation.- 5. Effects on Bronchial Responsiveness.- IV. Role in Asthma.- E. PAF.- I. Origin.- 1. Synthesis.- 2. Cellular Origin.- 3. Metabolism.- II. Receptors.- III. Airway Effects.- 1. Airway Smooth Muscle.- 2. Airway Secretions.- 3. Vascular Effects.- 4. Inflammatory Cell Activation.- 5. Bronchial Hyperresponsiveness.- IV. Role in Asthma.- 1. Release of PAF in Asthma.- 2. PAF Antagonists.- F. Kinins.- I. Formation and Metabolism.- II. Receptors.- III. Airway Effects.- IV. Role in Asthma.- G. Adenosine.- I. Origin.- II. Receptors.- III. Actions.- IV. Role in Asthma.- H. Complement.- I. Origin and Metabolism.- II. Receptors.- III. Airway Effects.- 1. Smooth Muscle Contraction.- 2. Vascular Effects.- 3. Mucus Secretion.- 4. Chemotaxis and Cell Activation.- 5. Bronchial Hyperresponsiveness:.- IV. Role in Asthma.- I. Serotonin.- I. Origin.- II. Receptors.- III. Airway Effects.- J. Chemotactic Factors.- K. Oxygen Radicals.- L. Conclusions.- References.- 4 Pharmacology of Airway Smooth Muscle.- A. Introduction.- B. E/C Coupling Mechanisms.- I. The Airway Smooth Muscle Cell.- II. Activator Calcium Ions and E/C Coupling.- 1. Coupling Mechanisms.- 2. Extracellular Activator Ca2+.- 3. Intracellular Activator Ca2+.- III. Biochemical Basis of Airway Smooth Muscle Contraction.- C. E/C Uncoupling Mechamisms.- I. ?-Adrenoceptor Agonists.- 1. ?-Agonist-Induced Relaxation In Vitro: General Properties.- 2. Role of Cyclic Adenosine Monophosphate (cAMP) Accumulation in the Relaxant Actions of ?-Adrenoceptor Agonists.- 3. ?-Agonists and the Ca2+ Sensitivity (or Responsiveness) of the Contractile Machinery.- 4. ?-Agonists and Inhibition of Ca2+ Influx.- 5. ?-Agonists and Inhibition of Ca2+ Release from Intracellular Stores.- 6. ?-Agonists and Promotion of Ca2+ Sequestration by Intracellular Stores.- 7. ?-Agonists and Ca2+ Extrusion.- II. Alkylxanthines.- 1. Alkylxanthine-Induced Relaxation In Vitro: General Properties.- 2. Role of cAMP Accumulation in the Relaxant Actions of Alkylxanthines..- 3. Alkyxanthines and Reduction in the Ca2+ Sensitivity (or Responsiveness) of the Contractile Machinery.- 4. Alkylxanthines and Inhibition of Ca2+ Influx.- 5. Alkylxanthines and Inhibition of Ca2+ Release from Intracellular Stores.- 6. Alkylxanthines and Promotion of Ca2+ Sequestration by Intracellular Stores.- 7. Alkylxanthines and Ca2+ Extrusion.- D. Future Trends in the Development of Bronchodilator Drugs.- References.- 5 Neural Mechanisms in Asthma.- A. Introduction.- B. Cholinergic Mechanisms.- I. Increased Vagal Tone.- II. Reflex Bronchoconstriction.- III. Increased Acetylcholine Release.- IV. Muscarinic Receptors.- V. Cholinergic Mechanisms in Asthma.- VI. Cholinergic Mechanisms in COAD.- VII. Muscarinic Receptor Subtypes.- C. Adrenergic Mechanisms.- I. Adrenergic Innervation.- II. Circulating Catecholamines.- III. ?-Adrenoceptors.- IV. ?-Adrenoceptors.- D. NANC Nerves and Neuropeptides.- I. NANC Inhibitory Nerves.- II. Increased NANC Excitatory Nerves.- III. Tachykinins.- IV. Calcitonin Gene-Related Peptide.- V. Axon Reflex Mechanisms.- VI. Modulation of NANC Bronchoconstriction.- E. Conclusions.- References.- 6 Pharmacology and Therapeutics of ?-Adrenoceptor Agonists.- A. Introduction.- B. The Molecular Nature of the ?-Adrenoceptor and Its Relationship to Adenylate Cyclase.- I. The ?-Adrenoceptor.- II. Regulatory Proteins.- III. Adenylate Cyclase.- IV. ?-Adrenoceptor Desensitization.- C. Density and Distribution of ?-Adrenoceptors in the Lung.- I. Radioligand Binding Studies.- II. Autoradiography.- 1. Trachea.- 2. Parenchyma.- D. Therapeutic Sites of Action.- I. Airway Smooth Muscle.- II. Secretory Cells and Cilia.- III. Tracheobronchial Microvessels.- IV. Cholinergic Nerves.- V. Mast Cells.- VI. Inflammatory Cells.- 1. Eosinophils.- 2. Lymphocytes.- 3. Polymorphonuclear Leukocytes.- 4. Macrophages.- 5. Platelets.- 6. Anti-Inflammatory Action in Asthmatic Airways.- E. The Status of ?-Adrenoceptor Function in Asthma.- I. In Vivo Studies.- II. In Vitro Studies.- 1. Isolated Human Leukocytes.- 2. Isolated Human Bronchi.- 3. Radioligand Binding Studies and Autoradiography in Lung.- F. The Importance of ?2-Adrenoceptor Selectivity and Efficacy.- I. ?2 Selectivity.- II. Efficacy.- G. Adverse Reactions to ?-Adrenoceptor Agonists.- I. Skeletal Muscle Tremor.- II. Cardiac Effects.- III. Changes in Plasma Constituents.- 1. Potassium.- 2. Glucose.- 3. Lipids.- IV. PaO2.- V. Neuropharmacological Effects.- VI. Hypersensitivity.- H. Therapeutic Actions of ?-Agonists.- I. Adrenaline.- II. Ephedrine.- III. Isoprenaline.- IV. Selective ?2-Agonists.- V. Prodrugs.- VI. Clinical Application.- I. Concluding Remarks.- References.- 7 Pharmacology of Anti-Asthma Xanthines.- A. Introduction.- I. Developmental Aspects.- II. Chemistry and Subdivision of Xanthines.- B. Clinical Use.- I. Acute Severe Asthma.- II. Chronic Asthma.- III. Chronic Obstructive Pulmonary Disorders.- C. Mode of Action of Xanthines.- I. Smooth Muscle Relaxation or Inhibition?.- II. Airway Anti-Inflammatory Actions.- III. Anti-Asthma Actions Outside the Airways?.- IV. Subcellular Mechanisms of Action.- V. Role of Endogenous Adenosine.- D. Conclusion.- References.- 8 Glucocotricosteroids in Asthma.- A. Mechanism of Action of Glucocorticosteroids.- I. Induction of Protein Synthesis.- 1. Lipocortins.- 2. Other Proteins Modulated by Glucocorticosteroids.- II. Effects on Cell Activation and Recruitment.- III. Other Effects.- 1. Vascular Permeability and Effects on Vascular Endothelium.- 2. Effects on ?-Adrenoceptors.- 3. Effects on Airway Function.- B. Clinical Use.- I. Pharmacokinetics of Steroids.- II. Routes of Administration.- 1. Oral.- 2. Intravenous.- 3. Inhaled.- III. Side Effects.- 1. Adrenal Suppression.- 2. Systemic Side Effects.- 3. Local Side Effects.- IV. Use in Clinical Practice.- 1. Acute Asthma.- 2. Chronic Asthma.- C. Future Developments.- References.- 9 Pharmacology of Prophylactic Anti-Asthma Drugs.- A. Cromoglycate and Nedocromil.- I. Cellular Pharmacology.- 1. Mast Cells and Basophils.- 2. Neutrophils, Eosinophils, Monocytes, and Platelets.- II. Biochemical Pharmacology.- III. Animal Pharmacology.- 1. Anaphylactic Bronchospasm.- 2. Sensory Reflexes.- IV. Human Pharmacology.- B. Ketotifen.- I. Pharmacology In Vitro.- II. Animal Pharmacology.- 1. Antihistamine, Antiallergic Properties.- 2. Inhibition of PAF-Induced Airway Hyperreactivity.- III. Human Pharmacology.- 1. Blockade of Responses to Spasmogens and Allergens.- 2. Reversal of ?-Adrenergic Receptor Tachyphylaxis.- 3. Double-Blind Placebo-Controlled Clinical Trials.- C. Pharmacological Analysis.- I. Cromoglycate and Nedocromil.- II. Ketotifen.- References.- 10 Pathophysiology and Pharmacology of Aspirin-Induced Asthma.- A. Introduction.- B. Definition and Main Clinical Features.- I. Major Offenders and Safe Alternatives.- II. Salicylates.- III. Paracetamol.- IV. Pyrazolones.- V. Tartrazine.- VI. Glucocorticosteroids.- C. Pathogenesis.- I. Allergic Mechanisms.- II. Abnormal Reactivity of Bradykinin Receptors.- III. Acetylation of Proteins.- IV. Complement Involvement.- V. The Cyclooxygenase Theory.- 1. Formulation of the Theory.- 2. Early Explanations.- 3. Participation of LTs.- 4. Platelet Involvement.- 5. Compartmentalization of Eicosanoids in the Lungs.- 6. Viral Infection.- D. Diagnosis.- E. Prevention and Therapy.- References.
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Publication date: January, 2012
Pages: 344
Weight: 522g
Availability: Available
Subcategories: Immunology, Pathology, Pharmacology, Physiology, Respiratory Medicine
From the same series
Roger G. Pertwee
Philip K. Moore
Kathleen M. Kantak
Alan Cowan
Hans-Georg Schaible
Arnold von Eckardstein
Mark A. Geyer
Botond Berde
Lorenzo A. Pinna
Arnold von Eckardstein
Mark A. Geyer
Anthony R.M. Coates
Vera Regitz-Zagrosek
Ursula F. Habenicht
Christoph Stein
Fabrizio Benedetti
Paolo Gresele
O. Eichler
Clive P. Page
Peter Ruben
G. Peters
Gary R. Lewin
Allison D. Fryer
Hans-Georg Joost
Vsevolod V. Gurevich
Hannsjorg W. Seyberth
Sharron H. Francis
George B. Koelle
Marc Humbert
G Kimmerle
Martha Merrow
Erich Gulbins
Martin C. Michel
Mathias Schwanstecher
Erich Gulbins
Martin F. Fromm
Ross G. Cameron
Hanns Mohler
Mark A. Geyer
F. Clementi
Peter Holzer
Gaetano Di Chiara
Anthony R. M. Coates
David S. Latchman
Siamon Gordon
Bernard Testa
Michael Oettel
B. Mayer
Klaus, von der Helm
Sheldon H. Preskorn
Lutz Hein
Heinz Nau
Stanley T. Crooke
J.M. Monti
Martin C. Michel
Vera Regitz-Zagrosek
Mark A. Geyer
G. Peters
Paolo Gresele
Manfred Gossen
Maynard B. Chenoweth
W. McD. Armstrong
Clive P. Page
Monika Schafer-Korting
Detlef Thieme
Fiona Cunningham
Vittorio Erspamer
Hans H. Ussing
Oskar Eichler
Ervin G. Erdös
S. Bettini
R.E.M. Bowden
John Morley
P.S. Randall
H. Winkler
R Jahn
J. Harenberg
F. Bachmann
D.J. Atherton
M.T. Jones
Frank A. Smith
Timothy D. Warner
Jochen Kuhlmann
James R. Gillette
Joel Bockaert
M. Chatterjee
A.P. Weetman
M. Sovak
James William Fisher
Hans-Georg Joost
D.I. Abramson
H.P. Witschi
R. Assan
Alfred J. Clark
J.M. van Rossum
Helmut Greim
Allison D. Fryer
Michael Oettel
M.L. Sears
R. Hess
P.E. Came
C.F. Arlett
H. Mehnert
W.N. Kelley
Luc P. Balant
Alan C. Sartorelli
Gregory R. Mundy
W. R. Martin
Peter Perlman
Michael B. Sporn
Harold C. Hodge
David R. Brown
C. Muller
J. Erik Jorpes
H.E. Voss
Peter Frederick Baker
Pedro Cuatrecasas
Laszlo Szekeres
Fritz Markwardt
R. Baserga
D.A. Kharkevich
H. Vanden Bossche
Stephen H. Caldwell
Ronald T. Borchardt
Alain L. de Weck
Lawrence E. Bryan
T.J. Campbell
F. Lang
K. Bartmann
Donald B. Calne
E.M. Johnson
G.H. Hitchings
Arnold L. Demain
Eugen Dorzbach
U. Peters
M. Green
A. S. Milton
R. Baurain
Brian W. Fox
W. Bleifeld
P. Actor
H. Vanden Bossche
Victor P. Whittaker
Ullrich Trendelenburg
D. Janz
Börje Uvnäs
H.G. Baumgarten
J. A. Nathanson
Frederick C. Kauffman
S. Silver
Kurt Greeff
B. Babudieri
J.G. Banwell
T.T. Aoki
A.L. Jr. Ager
M. Ackenheil
M. Rocha e Silva
Carlo Patrono
Hamao Umezawa
W. Rogalski
G. R. Strichartz
E.C. Foulkes
P. Needleman
E. Anggard
H. Schmidt
C. Braestrup
L.G. Abood
D.A. Kharkevich
C.-Y. Lee
Charles D. Kochakian
Robert Charlier
A.C. Allison
I.H. Page
James R. Gillette
Hermann Blaschko
K.W. Bock
Dean H. Lockwood
A. Dickenson
Franz von Bruchhausen
P.F. D'Arcy
Robert J. Kavlock
Andrew C.G. Uprichard
P.J. Lefebvre
Mervyn J. Eadie
Franz Hefti
Ross G. Cameron
John G. Csernansky
Michael J. Kuhar
Hannsjorg W. Seyberth
Sharron H. Francis
Mathias Schwanstecher
Martin C. Michel
Martin R. Wilkins
Martin F. Fromm
Peter Redfern
Klaus Aktories
Jurgen Behrens
Harri U. Vainio
Michael Williams
Dennis W. Choi
Gaetano Di Chiara
Peter Jonas
Salvador Moncada
Stefan Bauer
Markus Schwaiger
Markus Schwaiger
Jurgen Schuttler
Hans-Georg Krausslich
Veit M. Flockerzi
Harald H.H.W. Schmidt
Thomas C. Sudhof
Eric Beitz
Kian Fan Chung
Andreas Michael Zeiher
Yuti Chernajovsky
Jack E. Henningfield
Giovanna Lombardi
Salvador Moncada
Florian Holsboer
Enno Klussmann
Clive P. Page
Bertil B. Fredholm
Ursula F. Habenicht
Fiona Cunningham
Monika Schafer-Korting
Matthias Gaestel
Volker A. Erdmann
Robert E. Kass
Harald Sitte
Detlef Thieme
Domenico Spina
Constance N. Wilson
Jack E. Henningfield
Eric Beitz
Harald H.H.W. Schmidt
Giovanna Lombardi
Hans-Georg Krausslich
Kian Fan Chung
Markus Schwaiger
Markus Schwaiger
Enno Klussmann
Anna M. Wobus
Jurgen Schuttler
Thomas C. Sudhof
Stefan Bauer
Yuti Chernajovsky
Andreas Michael Zeiher
Veit M. Flockerzi
Christoph Stein
Salvador Moncada
Salvador Moncada
Harald Sitte